Dr Chris Harper


Special clinical interests in benign, urological, gastrointestinal, skin, neurological, head and neck, Stereotactic Ablative Body Radiotherapy and Steroetactic Radiosurgery.



Professional profile


Chris completed his initial medical and radiation oncology training in Western Australia, before undertaking post-graduate studies at Middlesex Hospital (UK), Princess Margaret Hospital (Toronto, Canada), and the Shands.

Cancer Centre (University of Florida, Gainesville, USA). He is the medical director at GenesisCare Wembley, holds a clinical staff position at Sir Charles Gairdner Hospital, and is accredited as a visiting consultant at a number of private hospitals.

Chris has specialised expertise in advanced radiotherapy techniques including stereotactic radiosurgery, stereotactic body radiation therapy, episcleral plaque brachytherapy for choroidal melanoma, and image guided radiation therapy, including IMRT. He has also completed training on the use of the CyberKnife® Robotic Radiosurgery System.

As an expert in his field, Chris has been involved with many notable committees. He was chairman of the Radiation Oncology Economics Committee, on the board of the Faculty of Radiation Oncology of the Royal Australian and New Zealand College of Radiologists (RANZCR), and more recently chairman of the Australian Association of Private Radiation Oncology Practices (AAPROP), to name but a few. He has also been a guest editor for the International Journal of Stereotactic Radiosurgery.

Chris is a member of the American Society for Therapeutic Radiation and Oncology (ASTRO), the International Stereotactic Radiosurgery Society (ISRS) and the Trans Tasman Radiation Oncology Group (TROG).
He has published over ten papers and is involved in ongoing research projects relating to predominantly prostate, intracranial, lung and spinal tumours.


  • Oncology